Header cover image

Swedish (OMX) Biotech Industry Analysis

UpdatedMay 14, 2022
DataAggregated Company Financials
Companies71
  • 7D2.5%
  • 3M-16.2%
  • 1Y-16.2%
  • YTD-27.9%

The Biotech industry is up 2.5% in the last week, with Swedish Orphan Biovitrum up 4.8%. In the same time, BioGaia was down 8.1%. In the past year, the industry is down 16%. Looking forward, earnings are forecast to grow by 36% annually.

Industry Valuation and Performance

Has the Swedish Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Sat, 14 May 2022kr146.6bkr21.4b-kr3,333,951,596.0045.3x
Mon, 11 Apr 2022kr176.5bkr19.7b-kr3,199,792,054.0051.1x
Wed, 09 Mar 2022kr145.5bkr19.6b-kr3,014,129,042.0046.7x
Fri, 04 Feb 2022kr171.5bkr19.1b-kr2,253,351,866.0051.8x
Sun, 02 Jan 2022kr200.6bkr19.1b-kr2,003,719,849.0053.3x
Tue, 30 Nov 2021kr201.1bkr19.0b-kr1,980,520,932.0053x
Thu, 28 Oct 2021kr200.3bkr18.9b-kr1,187,343,383.0054.4x
Sat, 25 Sep 2021kr212.4bkr18.1b-kr1,339,284,004.0051.8x
Mon, 23 Aug 2021kr193.7bkr18.1b-kr1,175,418,285.9554.5x
Sat, 10 Jul 2021kr170.4bkr18.1b-kr1,169,741,285.9558.6x
Fri, 02 Apr 2021kr148.3bkr17.8b-kr1,318,179,930.1043.9x
Mon, 04 Jan 2021kr162.3bkr18.7b-kr825,138,964.8551.9x
Thu, 08 Oct 2020kr170.0bkr19.1b-kr478,713,101.0752.1x
Wed, 01 Jul 2020kr145.8bkr19.1bkr28.3m42.2x
Sat, 04 Apr 2020kr106.0bkr19.3bkr512.8m39.4x
Tue, 07 Jan 2020kr115.4bkr17.9bkr501.4m39.3x
Mon, 30 Sep 2019kr108.8bkr16.0bkr194.9m39.1x
Thu, 04 Jul 2019kr122.6bkr15.4bkr616.5m36.3x
Median PE Ratio

35.4x


Total Market Cap: kr121.5bTotal Earnings: kr902.1mTotal Revenue: kr14.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Biotech Industry Median PE3Y Average 45.7x202020212022
Current Industry PE
  • Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 45.7x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 14% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market-1.98%
Healthcare2.52%
Biotech2.54%
Biotech2.54%
Industry PE
  • Investors are most optimistic about the Biotech industry, which is trading close to its 3-year average PE ratio of 45.7x.
  • Analysts are expecting annual earnings growth of 36%, which is higher than its past year's earnings decline of 7.3% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 36% over the next 5 years.
  • This is better than its past earnings decline of 7.3% per year.

    Top Stock Gainers and Losers

    Which companies have driven the market over the last 7 days?

    CompanyLast Price7D1YValuation
    SOBI Swedish Orphan Biovitrumkr210.604.8%
    +kr2.9b
    44.8%PS24.6x
    VITR Vitrolifekr231.607.1%
    +kr2.1b
    -25.0%PS102.8x
    PROB Probikr296.506.3%
    +kr199.4m
    -38.6%PS45.3x
    BIOA B BioArctickr74.352.3%
    +kr145.3m
    -4.3%PS308.9x
    IVACC Intervacckr32.005.5%
    +kr84.3m
    -56.4%PS179.9x
    Simply Wall St
    Simply Wall Street Pty Ltd
    17-21 Bellevue Street, Surry Hills, Sydney
    Download on the App StoreGet it on Google Play
    Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

    Latest News

    LIDDS

    kr8.76

    LIDDS

    7D

    29.4%

    1Y

    -13.4%

    PROB

    kr296.50

    Probi

    7D

    6.3%

    1Y

    -38.6%

    AEGIR

    kr18.71

    AegirBio

    7D

    -18.7%

    1Y

    -79.3%

    FLUO

    kr48.90

    FluoGuide

    7D

    -9.3%

    1Y

    -50.1%